About our project

The problem we solve: Our technology solves the problem of detecting and measuring the most complex human diseases non-invasively and sending the information remotely. The greatest advantage to the use of this technology is that it can be employed to detect and measure various types of blood content including, but not limited to electrolytes, metabolites, and small molecules such as amino Acids, DHEA and cortisol. We will also be able to detect proteins such as interleukins, tumor necrosis factor, and neuropeptides.

About our solution: Our technology is geared to detect specific signatures of glucose emitted from the epidermal layer of skin and is able to measure its exact levels in the blood from there. This can all be done on one device not much bigger than a quarter that is placed directly on the skin. The greatest advantage to the use of this technology is that it can be employed to detect and measure various types of blood content including, but not limited to electrolytes, metabolites, and small molecules such as amino Acids, DHEA and cortisol. We will also be able to detect proteins such as interleukins, tumor necrosis factor, and neuropeptides. We expect this technology to not only enable the creation of devices that will take over the CGM market, but also to change the scope of detection for various medical conditions around the world. In the process, with this technology we may even be able to end the need for blood draws forever. We are currently in a three stage prototyping process

About Our Company

How We Help Patients

It is important to note, that the Continuous Glucose Market(CGM) market is in its early stages and is rapidly growing. This is mainly due to a rise in the number of diabetics and numerous technological advancements. The CGM market will be valued at $2.9 Billion by 2021 and we believe that with our GDS device, we stand to capture 20% of this market by that time. The standard test strips which represent billions of dollars in spending per year will become obsolete as these CGM devices become more available, giving consumers more information in real time than ever before. Please keep in mind that the above is just the beginning of the scope of our technology.  It will cover much more, and will have the ability to monitor cancer patients, stroke patients, patients with neurological disorders and much much more.   We also plan to include marketing to patients in 5000 targeted hospitals, residents of senior facilities, home owners, Alzheimer’s Association members, cardiac patients, also individuals fighting Obesity, Diabetes, & Stroke, and those with,  Epilepsy, and fighting Paraplegic and Quadriplegic disorders, Spinal dangers, Sleep Apnea, Thyroid disease, high blood pressure, Cancer, Parkinson's, Blood clots, and individuals at high risk during travel.  To sum it up, we plan to do the following: 

•We monitor patients in the hospitals and in their homes by transmitting and receiving vital information from their glucose, cholestoral, and electrolytes readings that would be used in weight loss and physical fitness goals, including imaging records, cast wave files and video files which will create better tracking. Imagine an emergency and calling and sending for an ambulance and having the parametics receiving vital information on the patient before they arrive.  How powerful would that be? I would be a game-changer.  To sum it up, the major accomplishments that our technology promises are the following: 

•Give patients the ability to interact with their doctors and their caretakers real time and make needed course corrections in terms of their health.  

• Give patients the ability to non-invasively monitor Glucose, Aortic Blood Pressure, Cholestoral Readings, Electrolyte Readings, and much more . 

•Saves patient lives and money by creating a superior delivery system for remote health care utilizing advanced wireless technology including a method of incryption that will protect patient information.  

Finally, we need your support and will reward your gifts according the the patient reward section.  Please understand that we may need FDA approvals prior to giving out samples.  However we think we can give your pretty cool stuff for your support.  Help us to help humanity! 

How We Help Physicians

Unnessary hospital visits and medical false alarms drive up the cost of health care. 

•Creating real-time interaction between patients and providers

•Patient Falls: We have developed software and hardware that will be contained within our technology that will monitor patient falls

•Elopement:  Elopement can be a problem with Alzheimers patients where they get confusion and wander off from needed care.   Glucose Monitoring Device with its GPS system will allow caregivers to track those who may be putting themselves in danger and continue to monitor their health.  

•Staff Assistance:  The information on our device will can disseminated throughout a care facility allowing easy access to patients may have physical emergencies. 

Reporting: Real time recording and reporting of vitality information on a patient, is so important, we truly believe that it is the bread and butter of efficient patient care, this coupled with giving the patient the technology to interact with providers so that they can make meaningful and necessary course corrections based upon instruction coming from their primary care providers. We have developed technology covered in our patent that will give the primary care provider the ability to monitor and interact with as many patients as need be, and give providers a treasure chest of meaningful applications which will increase job efficiency:.  

Applications:

  People tracking inside and outdoors

  Can be adapted for Autistic Patient tracking indoors and outdoors

  Can be adapted for Diabetes Patient needs

  Can be adapted for Cardiac Patient needs

  Can be adapted for a variety of other special needs Patient tracking and trace

  Can be adapted for  Sleep Apnea Patients

  Can be adapted to Alzheimer's  Patients

  Can  be adapted  for children and adults with cognitive disabilities to enhance safety

How We Help Hospitals

It is important to note, that the Continuous Glucose Market(CGM) market is in its early stages and is rapidly growing. This is mainly due to a rise in the number of diabetics and numerous technological advancements. The CGM market will be valued at $2.9 Billion by 2021 and we believe that with our GDS device, we stand to capture 20% of this market by that time. The standard test strips which represent billions of dollars in spending per year will become obsolete as these CGM devices become more available, giving consumers more information in real time than ever before. Please keep in mind that the above is just the beginning of the scope of our technology.  It will cover much more, and will have the ability to monitor cancer patients, stroke patients, patients with neurological disorders and much much more.   We also plan to include marketing to patients in 5000 targeted hospitals, residents of senior facilities, home owners, Alzheimer’s Association members, cardiac patients, also individuals fighting Obesity, Diabetes, & Stroke, and those with,  Epilepsy, and fighting Paraplegic and Quadriplegic disorders, Spinal dangers, Sleep Apnea, Thyroid disease, high blood pressure, Cancer, Parkinson's, Blood clots, and individuals at high risk during travel.  To sum it up, we plan to do the following: 

•We monitor patients in the hospitals and in their homes by transmitting and receiving vital information from their glucose, cholestoral, and electrolytes readings that would be used in weight loss and physical fitness goals, including imaging records, cast wave files and video files which will create better tracking. Imagine an emergency and calling and sending for an ambulance and having the parametics receiving vital information on the patient before they arrive.  How powerful would that be? I would be a game-changer.  To sum it up, the major accomplishments that our technology promises are the following: 

•Give patients the ability to interact with their doctors and their caretakers real time and make needed course corrections in terms of their health.  

• Give patients the ability to non-invasively monitor Glucose, Aortic Blood Pressure, Electrolyte readings, and much more . 

•Saves patient lives and money by creating a superior delivery system for remote health care utilizing advanced wireless technology including a method of incryption that will protect patient information.  

Finally, we need your support and will reward your gifts according the the patient reward section.  Please understand that we may need FDA approvals prior to giving out samples.  However we think we can give your pretty cool stuff for your support.  Help us to help humanity! 

How We Help Partners

 In the month of August we received Endorsement from the University of Arkansas which is open to use its faculty and staff to build our device from our present prototype, to the ready for market edition, including setting up manufacturing, and facilitating partnerships globally working hand-in-hand with Fallbrook Engineering of Luecacia California.  Fallbrook Engineering was established in 1981 and is one of the premire engineering firms in the country specializing in medical device development and manufacturing. Further, Fallbrook is one of the top developers of medical devices doing work for major hospitals such as Scripps La Jolla---They are co-inventors of the latest stent technologies along with Dr. Paul Tierstien MD Chief of Cardiology at Scripps and they do a lot of work with Qualcomm) .  Putting these two companies together creates a powerful team geared to successfully solve the challenge of non-invasive diabetic monitoring.  The University is interested in the huge impact that a truly non-invasive, wireless wearable device will have on Glucose reading and monitoring, and disease management.  ie. Cancer, neurological diseases and chemical dependencies.  Given this backdrop, a parnership with a hospital, provider, or device company who is willing to provide needed financing will be key in attaining the success necessary to create a revolutionary working piece of technology that provides the technology to monitor diabetes which has become the worst plagues of our society.  

The partnership with a medical provider, physician or medical device company who has the connections and established markets for Aortic blood pressure reading, weight loss, and Kiosk applications would stand be the forefront to a billion dollar industry. Lastly, the University will need funding to complete its work and will work in conjunction with our engineers, and those of Fallbrook Engineering.

We are currently completing the second stage of our prototype development at this stage we are building a chamber the size of a shoe box that will read gasses from the epidermis.  The shoebox chamber would be used in Kiosks at Rite Aids and CVS stores.  It would replace the current methods of reading blood pressure and give the user a much broader scope of measuring pertainent health and vitality information.  

3. We are in private talks with US based Molex Engineering, FoxConn of Tiawan, and Huawei of China.  We have garnered major interest from several major companies who is looking for us to develop an aspect of our technology.  Yet, we believe the best partnership would be with a device company who already had established markets in our technological space.  We are interested in meaningful long-term partnerships that can help channel a technology that will be as revolutionary to the medical device industry as apple was to the computer industry.  

Challenge Mission

Innovation Details

Intellectual Property Summary

Our newest technology has been recently converted from a provisional patent to a utility patent application No.: 14/933985. Our patent attorneys are Knobbe Martens one of the largest most recognized patent firms in the world.  We also have 2 provisional patents connected with our foundational patent covering specific areas of technology under development.  Additionally, we also have an issued patent on swimming technology US Patent #8,659,435 B2. drowning is the third leading cause of unintentional injury resulting in death. The most effective way to combat this killer is to raise the alarm as soon as a swimmer is experiencing trouble by detecting, reading and transposing the human vitality signals of humans and sending them to a remote location. https://patents.google.com/patent/US20110241887A1/en?q=waterproof&q=optically&q=sensing&q=fiberless

Clinical Information

We plan to have a non-FDA marketed device and a version which will require FDA  Class 2 approval.  Our sports rendention of our device will detect potassium, magnesium, sodium levels and  vitamin D.  This will be used in professional and amateur sports.  We also are developing a device that will be integrated into cell phone technology. Finally, we have enlisted the help of the University of Arkansas and have a letter of commitment from the University that is available upon request.  

Regulatory Status

 We have enlisted the services of Fallbrook Engineering in Luecadia to be our contracted design manufacturer and development contractor for medical devices. Since 1981, Fallbrook has been specialized in medical device development with extensive experience in developing monitoring devices for the diabetic market. They have developed medical devices for some of the largest medical device companies in the world including names like Medronics.  They also developed one one of the greatest technological developments in stent technology with Scripts and hold a joint patent with Dr. Paul Tierstien who is head of Cardiology at Scripts. They will be assisting us to create the functioning prototype and they have an extensive background in pursuing all FDA approvals. 

How we will use the funds raised

Our funds will be used to complete the building of our chamber. The chamber comes with a gasket sealed opening which will allow entry of a human sample for readings in addition to controlled samples and complex customized optic sensors and photospectrometers and other sensing devices that we have developed with our collaborators to complete our chamber. Once fully completed, our chamber will be able to detect Glucose, Electrolytes, Cardio disorders, and much more. Finally funding at this stage will allow us to perform spectral wavelength readings which must be crossed referenced with a database that will reveal the properties of the control sample and display on the front of our chamber. Once we have completed our chamber we will be developing a specialized chamber for the detection and monitoring of cancer and other complex diseases. 

Thank You

We need your support, because we will change the world by allowing people to monitor diseases in a way that is easy and efficient. It strongly believe it will save the health care industry billions of dollars. Please consider that none of the devices that fall within our current competition employ the technology of our GDS device, and none will be able to claim the consistency, and accuracy that we will achieve.  All of the other technologies need to be calibrated with the traditional invasive blood sugar monitoring.  In addition, our technology does not have a ceiling of what other substances can be detected. Our future is not limited to only detecting blood chemicals, but we will be able to impact the body itself by detecting cancer markers or employing gene therapy. Your contribution will go toward making history, you vote is important and valuable in helping to relieve human suffering gobally.  Join us!!!  We appreciate your support!!!

Supporters

• 
  EM Walls
  11/16/2016 - Liked the project.
• 
  Suraj Vid
  11/14/2016 - Interested in helping your project as a mentor or team member.
• 
  Suraj Vid
  11/14/2016 - Followed the project.
• 
  Errie Bohanon
  11/12/2016 - Liked the project.

Comments

Updates

• Update #1

  15th November, 2016

  Partnerships

  We are open to partners who have technologies that can work in conjunction with our own cutting-edge technology. We also encourage investors who can have an ownership interest Better Life Technologies its patents and areas of patent technology that is still pending. Please let me know of your interest by emailing me at gmckinney@betterlifetech.net

---